Birchwood Financial Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53.6K Hold
930
0.04% 162
2026
Q1
$56.4K Hold
930
0.05% 150
2025
Q4
$50.2K Buy
+930
New +$44.7K 0.05% 168

Other funds holding BMY

Birchwood Financial Partners's BMY Position: Q2 2026 in Review

Birchwood Financial Partners held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 930 shares worth $53.6K. The position accounts for 0.04% of the portfolio, ranked #162.

Birchwood Financial Partners first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $56.4K in Q1 2026. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Birchwood Financial Partners held 930 shares of Bristol-Myers Squibb worth $53.6K as of Q2 2026.
  • Birchwood Financial Partners left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.04% of Birchwood Financial Partners's portfolio in Q2 2026, its #162 holding.
  • Birchwood Financial Partners first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • Birchwood Financial Partners's Bristol-Myers Squibb position peaked at $56.4K in Q1 2026.
  • 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Birchwood Financial Partners's 13F filing for Q2 2026, filed 6 Aug 2026.